Data-driven, molecular insights are changing the landscape of precision medicine and Caris Life Sciences® is uniquely positioned to support biopharma and other precision medicine partners with actionable insights from retrospective, epidemiologic and real time molecular data to enhance research and commercial activities.

One of the world’s largest molecular information databases, with learnings from more than 100,000+ clinical cases, includes:

  • Biomarker frequency and expression rates
  • DNA, RNA and protein status
  • Wide range of tumor types
  • Multiple technology platforms – view technologies
  • General demographic information
  • De-identified/HIPAA compliant

MI Insights to Inform:

• Clinical Trial Design   • Commercial Operations and Strategy

• Companion Dx Development

  • Indication Expansion or Selection  • Population Prevalence